FOX RUN MANAGEMENT, L.L.C.
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1533457
GREENWICH, CT
Position in ARWR
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$398,583
-$307,263 QoQ
Shares Held
4,890
-91.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#315
of 497 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $29,784,980 across 59 Biotechnology names. ARWR ranks #30 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAMS |
NewAmsterdam Pharma Co N.V.
|
59,477 | $2,015,675 | |
| 2 | RPRX |
Royalty Pharma plc
|
24,094 | $1,350,950 | |
| 3 | IMVT |
Immunovant, Inc.
|
34,827 | $1,341,884 | |
| 4 | ASND |
Ascendis Pharma A/S
|
4,726 | $1,260,518 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
28,315 | $1,104,568 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
38,178 | $1,001,027 | |
| 7 | EXEL |
Exelixis, Inc.
|
18,255 | $993,254 | |
| 8 | EYPT |
EyePoint, Inc.
|
58,528 | $836,950 |
All Filings in ARWR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $398,583 | 4,890 | Shares | Sole | 2026-08-04 | |
| 2025-03-31 | $705,846 | 55,404 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $984,029 | 52,342 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,085,223 | 56,026 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,169,264 | 44,989 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $803,602 | 28,098 | Shares | Sole | 2024-05-13 | |
| 2023-09-30 | $316,528 | 11,780 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $313,522 | 8,792 | Shares | Sole | 2023-08-11 | |
| 2021-12-31 | $220,779 | 3,330 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||